Douglas J Perkins Selected Research

Parasitic Diseases (Parasitic Disease)

6/2007	Higher production of peripheral blood macrophage migration inhibitory factor in healthy children with a history of mild malaria relative to children with a history of severe malaria.
5/2006	Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Douglas J Perkins Research Topics

Disease

35	Malaria 09/2023 - 01/2002
31	Anemia 09/2023 - 08/2004
14	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2019 - 01/2004
12	Infections 08/2023 - 11/2003
11	Parasitemia 01/2016 - 11/2003
7	COVID-19 08/2023 - 01/2020
5	Bipolar Disorder (Manic Depressive Psychosis) 04/2021 - 01/2016
5	Bacteremia 01/2019 - 01/2007
5	Acute malaria 07/2012 - 07/2005
4	Coinfection 01/2016 - 01/2002
3	Sickle Cell Trait 06/2023 - 11/2011
3	Cerebral Malaria 07/2013 - 05/2005
3	Communicable Diseases (Infectious Diseases) 03/2013 - 09/2006
2	Glucosephosphate Dehydrogenase Deficiency 12/2011 - 11/2011
2	Parasitic Diseases (Parasitic Disease) 06/2007 - 05/2006
2	HIV Infections (HIV Infection) 12/2004 - 01/2002
1	Shock 08/2023
1	Brain Diseases (Brain Disorder) 08/2023
1	Hemoglobinopathies 06/2023
1	alpha-Thalassemia 06/2023
1	Child Nutrition Disorders 01/2021
1	Leishmaniasis 01/2021
1	Diabetes Mellitus 01/2020
1	Psychotic Disorders (Schizoaffective Disorder) 12/2018
1	Hypothyroidism 01/2016

Drug/Important Bio-Agent (IBA)

16	Hemoglobins (Hemoglobin)IBA 09/2023 - 05/2005
12	hemozoinIBA 03/2022 - 11/2003
10	CytokinesIBA 01/2017 - 01/2002
7	Interleukin-12 (IL 12)IBA 01/2016 - 01/2002
6	Interleukin-10 (Interleukin 10)IBA 01/2016 - 01/2004
5	InterleukinsIBA 03/2013 - 01/2002
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2008 - 05/2005
4	Antipsychotic Agents (Antipsychotics)IBA 01/2020 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 07/2019 - 01/2002
4	Dinoprostone (PGE2)FDA Link 07/2013 - 01/2004
4	Macrophage Migration-Inhibitory FactorsIBA 08/2009 - 05/2006
3	insulin receptor-related receptor (IRR)IBA 09/2023 - 01/2022
3	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 06/2023 - 11/2011
3	ProstaglandinsIBA 01/2020 - 01/2004
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2020 - 01/2004
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019 - 01/2016
3	LithiumIBA 01/2019 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2011
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 07/2013 - 05/2005
3	Interleukin-13IBA 03/2013 - 11/2011
3	Prostaglandins EIBA 08/2012 - 11/2003
3	Immunoglobulin G (IgG)IBA 03/2012 - 04/2006
3	Chemokine CCL5IBA 07/2009 - 07/2005
3	ChemokinesIBA 10/2006 - 01/2002
2	DNA (Deoxyribonucleic Acid)IBA 06/2023 - 01/2006
2	Drug CombinationsIBA 01/2020 - 01/2019
2	Antidepressive Agents (Antidepressants)IBA 01/2019 - 12/2018
2	Interleukin-7 (Interleukin 7)IBA 01/2019 - 01/2016
2	Interleukin-17 (Interleukin 17)IBA 01/2017 - 01/2016
2	CreatinineIBA 07/2013 - 05/2005
2	InterferonsIBA 08/2012 - 01/2002
2	AntibodiesIBA 03/2012 - 04/2006
2	Interleukin-18 (Interleukin 18)IBA 12/2011 - 01/2002
2	Interleukin-12 Subunit p40IBA 02/2008 - 09/2006
1	Natural Cytotoxicity Triggering Receptor 3IBA 09/2023
1	Natural Killer Cell ReceptorsIBA 09/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2023
1	ORALIT (ORS)IBA 12/2022
1	Complement C3 (C3 Complement)IBA 01/2022
1	Complement C5 (Complement 5)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Protein Disulfide-IsomerasesIBA 01/2021
1	Amodiaquine (Camoquin)FDA Link 12/2020
1	Clopenthixol (Zuclopenthixol)IBA 12/2020
1	remdesivirIBA 12/2020
1	favipiravirIBA 12/2020
1	Nebivolol FDA Link 12/2020
1	Antiviral Agents (Antivirals)IBA 12/2020
1	artemisinin (artemisinine)IBA 10/2020
1	Investigational DrugsIBA 10/2020
1	Neutralizing AntibodiesIBA 10/2020
1	2-thioxo-4-thiazolidinecarboxylic acid (TTCA)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	tyrosyl-tyrosyl-glutamyl-glutamic acidIBA 01/2020
1	Complement C1q (C1q Complement)IBA 07/2019
1	lipoteichoic acidIBA 01/2019
1	LipopolysaccharidesIBA 01/2019
1	NF-kappa B (NF-kB)IBA 10/2016
1	Glutamine (L-Glutamine)FDA Link 10/2016
1	Inflammation MediatorsIBA 01/2016
1	Oxcarbazepine (Trileptal)FDA LinkGeneric 01/2016
1	Interleukin-4 (Interleukin 4)IBA 01/2016
1	Interleukin-5 (Interleukin 5)IBA 01/2016
1	Interleukin-15 (Interleukin 15)IBA 01/2016
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2016
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 01/2014
1	piperaquineIBA 01/2014

Therapy/Procedure

5	Therapeutics 12/2020 - 01/2016
4	Drug Therapy (Chemotherapy) 04/2021 - 12/2018
3	N95 Respirators 01/2021 - 01/2020
2	Polypharmacy 01/2020 - 01/2019
1	Artificial Respiration (Mechanical Ventilation) 08/2023
1	Length of Stay 01/2022
1	Art Therapy 01/2021
1	Aftercare (After-Treatment) 12/2018